Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.60 |
| ▸ | GNAI3 | P08754 | 3/20 | 0.56 |
| ▸ | GNAO1 | P09471 | 3/20 | 0.56 |
| ▸ | GNAI1 | P63096 | 3/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | PRCP | P42785 | 2/20 | 0.51 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2404722 | 0.87 | HSD17B10 (0.46) | NAAAGNAI3GNAO1GNAI1POLB | |
| SCHEMBL23374501 | 0.87 | HSD17B10 (0.46) | NAAAGNAI3GNAO1GNAI1POLB | |
| SCHEMBL19188081 | 0.81 | NAAA (0.47) | NAAAGNAI3GNAO1GNAI1POLB | |
| SCHEMBL15304131 | 0.81 | NAAA (0.58) | NAAAGNAI3GNAO1GNAI1POLB | |
| SCHEMBL671223 | 0.80 | ALDH1A1 (0.49) | NAAAGNAI3GNAO1GNAI1POLB | |
| SCHEMBL1678750 | 0.80 | NAAA (0.83) | NAAAGNAI3GNAO1GNAI1PRCP | |
| SCHEMBL9511929 | 0.80 | NAAA (0.83) | NAAAGNAI3GNAO1GNAI1PRCP | |
| Dodecane SCHEMBL28221466 | 0.79 | POLB (0.44) | NAAAPOLB | |
| SCHEMBL377246 | 0.78 | NAAA (0.79) | NAAAGNAI3GNAO1GNAI1PRCP | |
| SCHEMBL9925959 | 0.78 | KMT2A (0.46) | NAAAGNAI3GNAO1GNAI1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8795647-B2 | Alternating ring-opening metathesis polymerization | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2014-08-05 | — | — | US | disclosed |
| US-20110212046-A1 | ALTERNATING RING-OPENING METATHESIS POLYMERIZATION | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2011-09-01 | — | — | US | disclosed |
| WO-2010022284-A1 | ALTERNATING RING-OPENING METATHESIS POLYMERIZATION | THE RESEARCH FOUNDATION OF THE STATE UNIVERSITY OF NEW YORK (US) | 2010-02-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110212046-A1 | ALTERNATING RING-OPENING METATHESIS POLYMERIZATION | PARG, PIN1, PARP4 | NAAA 866/4885GNAI3 2491/4885GNAO1 2738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.